Furthermore, bicyclic stapled peptides based on p53 were developed by combining all-hydrocarbon stapling and lactam stapling strategies, yielding constructs such as p53-16, which exhibited nanomolar affinity toward MDM2 and MDMX and selectively activated the p53 pathway to inhibit tumor cell growth in vitro [37]. Here, TP53 is linked to neoplasm.